KALA BIO Statistics
Total Valuation
KALA BIO has a market cap or net worth of $28.57 million. The enterprise value is $12.23 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
KALA BIO has 4.61 million shares outstanding. The number of shares has increased by 53.04% in one year.
Current Share Class | 4.61M |
Shares Outstanding | 4.61M |
Shares Change (YoY) | +53.04% |
Shares Change (QoQ) | +52.71% |
Owned by Insiders (%) | 3.91% |
Owned by Institutions (%) | 17.03% |
Float | 2.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.16 |
P/TBV Ratio | 2.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 2.68 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.88 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -51.52% |
Revenue Per Employee | n/a |
Profits Per Employee | -$906,116 |
Employee Count | 43 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.94% in the last 52 weeks. The beta is -2.14, so KALA BIO's price volatility has been lower than the market average.
Beta (5Y) | -2.14 |
52-Week Price Change | +3.94% |
50-Day Moving Average | 6.06 |
200-Day Moving Average | 6.58 |
Relative Strength Index (RSI) | 43.49 |
Average Volume (20 Days) | 32,701 |
Short Selling Information
The latest short interest is 37,467, so 0.81% of the outstanding shares have been sold short.
Short Interest | 37,467 |
Short Previous Month | 29,281 |
Short % of Shares Out | 0.81% |
Short % of Float | 1.34% |
Short Ratio (days to cover) | 1.91 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -40.32M |
Pretax Income | -38.72M |
Net Income | -38.96M |
EBITDA | -40.06M |
EBIT | -40.32M |
Earnings Per Share (EPS) | -$11.81 |
Full Income Statement Balance Sheet
The company has $54.20 million in cash and $36.80 million in debt, giving a net cash position of $17.40 million or $3.78 per share.
Cash & Cash Equivalents | 54.20M |
Total Debt | 36.80M |
Net Cash | 17.40M |
Net Cash Per Share | $3.78 |
Equity (Book Value) | 13.72M |
Book Value Per Share | 2.98 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KALA BIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -53.04% |
Shareholder Yield | -53.04% |
Earnings Yield | -131.51% |
FCF Yield | n/a |
Analyst Forecast
The average price target for KALA BIO is $15.00, which is 141.94% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 141.94% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.
Last Split Date | Oct 21, 2022 |
Split Type | Reverse |
Split Ratio | 0.02:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |